Clinical-stage pharmaceutical company that develops treatments for Central Nervous System (CNS) conditions
NeuroDerm has raised €12M across 1 funding round, most recently a Growth/Late round in Aug 2014. Based in Israel; founded 2003; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2014-08-01 | Growth/Late | €12M |
| — |
| View deal → |
